Guido Ghilardi

Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy

Melody Smith, Anqi Dai, Guido Ghilardi et al. · Nature Medicine · 2022 · 285 citations · Full text

Dysbiosis, Allergy, Gut Microbiome Correlates +10

T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy

Guido Ghilardi, Joseph A. Fraietta, James N. Gerson et al. · Nature Medicine · 2024 · 231 citations

Lymphoid Neoplasia, Radiation Oncology, Cancer Immunosurveillance +10

Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia

Davide Rossi, Lodovico Terzi-di-Bergamo, Lorenzo De Paoli et al. · Blood · 2015 · 212 citations · Full text

Genetic and phenotypic attributes of splenic marginal zone lymphoma

Ferdinando Bonfiglio, Alessio Bruscaggin, Francesca Guidetti et al. · Blood · 2021 · 93 citations · Full text

Immunology, Pathology, Phenotypic Attributes +21

Bendamustine is safe and effective for lymphodepletion before tisagenlecleucel in patients with refractory or relapsed large B-cell lymphomas

Guido Ghilardi, Elise A. Chong, Jakub Svoboda et al. · Annals of Oncology · 2022 · 89 citations · Full text

Lymphoid Neoplasia, Large B-cell Lymphomas, Medicine +7